08:04 EDT Kazia Therapeutics (KZIA) files to sell 232,956 American Depositary Shares for holders
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KZIA:
- Two new option listings and nine option delistings on September 22nd
- Buy Rating for Kazia Therapeutics Driven by Promising Paxalisib Developments in Cancer Treatment
- Kazia Therapeutics Achieves Breakthrough in Breast Cancer Treatment with Paxalisib
- Kazia Therapeutics’ paxalisib monotherapy shows tumor cell cluster disruption
- Kazia Therapeutics Secures $2 Million in Private Placement to Advance Oncology Programs